Arcellx, Inc.

Arcellx, Inc. - ROEverified

ACLX

Price:

$115.07

Market Cap:

$6.73B

Arcellx, Inc. is a clinical-stage biotechnology enterprise dedicated to pioneering immunotherapeutic solutions for patients battling cancer and other intractable diseases. A cornerstone of their pipeline is CART-ddBCMA, an advanced ddCAR product candidate currently undergoing a Phase 1 clinical trial. This investigational treatment targets individuals suffering from relapsed or refractory multiple myeloma (MM). Beyond their lead candidate, Arcellx is also advancing ACLX-001, an immunotherapy composed of ARC-T cells and bi-valent SparX proteins engineered to combat r/r MM by targeting BCMA. Their development efforts extend to ACLX-002 and ACLX-003, designed to address relapsed or refractory a...[Read more]

Industry

Biotechnology

IPO Date

2022-02-04

Stock Exchange

NASDAQ

Ticker

ACLX

The ROE as of June 2026 (TTM) for Arcellx, Inc. (ACLX) is -55.42%

According to Arcellx, Inc.’s latest financial reports and current stock price. The company's current ROE is -55.42%. This represents a change of 299.53% compared to the average of -13.87% of the last 4 quarters.

Arcellx, Inc. (ACLX) Historical ROE (quarterly & annually)

How has ACLX ROE performed in the past?

The mean historical ROE of Arcellx, Inc. over the last ten years is -25.22%. The current -55.42% ROE has changed 119.73% with respect to the historical average. Over the past ten years (40 quarters), ACLX's ROE was at its highest in in the December 2021 quarter at 17.01%. The ROE was at its lowest in in the September 2022 quarter at -39.31%.

Quarterly (TTM)
Annual

Average

-25.22%

Median

-40.25%

Minimum

-92.06%

Maximum

54.90%

Arcellx, Inc. (ACLX) ROE by Quarter and Year

Discovering the peaks and valleys of Arcellx, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 141.06%

Maximum Annual ROE = 54.90%

Minimum Annual Increase = -272.18%

Minimum Annual ROE = -92.06%

Quarterly (TTM)
Annual
YearROEChange
2025-56.90%141.06%
2024-23.60%62.07%
2023-14.56%-84.18%
2022-92.06%-272.18%
202153.47%-184.19%
2020-63.50%-215.68%
201954.90%-192.24%

Arcellx, Inc. (ACLX) Average ROE

How has ACLX ROE performed in the past?

The current ROE of Arcellx, Inc. (ACLX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-31.69%

5-year avg

-26.73%

10-year avg

-25.22%

Arcellx, Inc. (ACLX) ROE vs. Peers

How is ACLX’s ROE compared to its peers?

Arcellx, Inc.’s ROE is less than Alkermes plc (8.82%), greater than NewAmsterdam Pharma Company N.V. (-29.80%), greater than Akero Therapeutics, Inc. (-30.68%), greater than Protagonist Therapeutics, Inc. (-17.76%), greater than Arrowhead Pharmaceuticals, Inc. (-55.45%), greater than Kymera Therapeutics, Inc. (-25.02%), greater than Viking Therapeutics, Inc. (-71.31%), greater than Immunovant, Inc. (-68.16%), greater than CRISPR Therapeutics AG (-30.88%), greater than Vaxcyte, Inc. (-32.51%),

Build a custom stock screener for Arcellx, Inc. (ACLX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arcellx, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Arcellx, Inc. (ACLX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Arcellx, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Arcellx, Inc.'s ROE?

How is the ROE calculated for Arcellx, Inc. (ACLX)?

What is the highest ROE for Arcellx, Inc. (ACLX)?

What is the 3-year average ROE for Arcellx, Inc. (ACLX)?

What is the 5-year average ROE for Arcellx, Inc. (ACLX)?

How does the current ROE for Arcellx, Inc. (ACLX) compare to its historical average?